Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Genervon Biopharmaceuticals LLC
DescriptionEndogenous embryonic stage peptide that binds to a subunit of insulin receptor (INSR), insulin-like growth factor-1 (IGF-1) receptor (IGF1R; CD221) and IGF2R
Molecular Target Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221) ; Insulin-like growth factor-2 (IGF-2) receptor (IGF2R) (M6PR)
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today